Use of hydroxychloroquine to control immune response and hypercoagulability in patients with primary antiphospholipid syndrome

Published: 4 June 2021
Author(s): Sabrina Saraiva-Mangolin, Camila de Oliveira Vaz, Thays Ruiz, Bruna Moraes Mazetto, Fernanda Andrade Orsi
Issue: August 2021
Section: Letter to the Editor
Read on EJIM website

Dear Editor,

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More